The degree of impact can depend on individual health conditions and should be evaluated by a healthcare provider.
Biosci Rep (2020) 40(4):BSR20193160
Before the promising therapeutic impact of miRNA can be realized, there are several challenges to be addressed, which include but not limited to targeted delivery of oligonucleotides to specific organs, tissues and cell types, poor bioavailability, limited tissue permeability (Stylianopoulos and Jain, 2013), potential drug resistance, and instability (Raemdonck et al., 2008)
The addition of KPV to the GLOW formulation specifically addresses inflammatory barriers to healing, creating a more complete regenerative environment
If you are still evaluating outcomes and expectations, you may find it helpful to read Does IV vitamin therapy really work
or if one is undergoing bone marrow treatment